Abstract
Glycogen synthase kinase (GSK)-3β is a conserved serine/threonine protein kinase highly abundant in brain tissue. A dominant mechanism by which cells react to stress involves GSK-3β. We studied the effect of stress on GSK-3β levels ex vivo. We have previously found reduced GSK-3β protein levels and GSK-3 activity in postmortem prefrontal cortex of schizophrenic patients. Since schizophrenic patients experience stress more severely than healthy people, we questioned whether their GSK-3β reduction is stress-related using a rat model. Rats were exposed to acute, subchronic, or chronic stress using brief cold restraint. No effect was found on frontal cortex GSK-3β protein levels. These results suggest that reduction in GSK-3β levels in schizophrenic patients is not affected by cold restraint stress and supports the possibility that the changes observed in postmortem brains may be related to the disease.
Original language | English |
---|---|
Pages (from-to) | 1309-1312 |
Number of pages | 4 |
Journal | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
Volume | 26 |
Issue number | 7-8 |
DOIs | |
State | Published - 1 Dec 2002 |
Keywords
- Animal model
- Cold restraint stress
- Frontal cortex
- Glycogen synthase kinase-3β (GSK-3β)
- Protein levels
- Schizophrenia
ASJC Scopus subject areas
- Pharmacology
- Biological Psychiatry